PMID- 29737898 OWN - NLM STAT- MEDLINE DCOM- 20181003 LR - 20200225 IS - 2058-7384 (Electronic) IS - 0394-6320 (Print) IS - 0394-6320 (Linking) VI - 32 DP - 2018 Jan-Dec TI - Exposure to low-dose bisphenol A during the juvenile period of development disrupts the immune system and aggravates allergic airway inflammation in mice. PG - 2058738418774897 LID - 10.1177/2058738418774897 [doi] LID - 2058738418774897 AB - Bisphenol A (BPA) is used in the production of polycarbonate plastics and epoxy resins and found in many consumer products. Previous studies have reported that perinatal exposure to BPA through the oral route promotes the development of allergic airway inflammation. We investigated the effects of exposure to low-dose BPA during the juvenile period of development on allergic airway inflammation. Six-week-old male C3H/HeJ mice were intratracheally administered ovalbumin (OVA, 1 mug) every 2 weeks and/or BPA (0, 0.0625, 1.25, and 25 pmol/animal/week) once per week for 6 weeks. Following the final intratracheal instillation, we examined the cellular profile of the bronchoalveolar lavage fluid, histological changes and expression of inflammatory/anti-inflammatory mediators in the lungs, OVA-specific immunoglobulin (Ig) production, serum corticosterone levels, and changes in the lymphoid tissues (mediastinal lymph node (MLN) and spleen). Exposure to OVA + BPA enhanced inflammatory cell infiltration and protein expression of Th2 cytokines/chemokines (e.g. interleukin (IL)-13 and IL-33) in the lungs, OVA-specific immunoglobulin E (IgE) production, the numbers of total cells and activated antigen-presenting cells (MHC class II(+) CD86(+), CD11c(+)), as well as the production of Th2 cytokines (i.e. IL-4 and IL-5) and stromal cell-derived factor-1alpha in MLN cells compared to OVA exposure alone. These effects were more prominent with 0.0625 or 1.25 pmol/animal/week of BPA. Furthermore, exposure to OVA + BPA altered serum levels of anti-inflammatory corticosterone, estrogen receptor 2 messenger RNA (mRNA) expression in the lungs and spleen functionality. These findings suggest that low-dose BPA exposure may aggravate allergic airway inflammation by enhancing Th2 responses via disruption of the immune system. FAU - Koike, Eiko AU - Koike E AD - 1 Center for Health and Environmental Risk Research, National Institute for Environmental Studies, Tsukuba, Japan. FAU - Yanagisawa, Rie AU - Yanagisawa R AD - 1 Center for Health and Environmental Risk Research, National Institute for Environmental Studies, Tsukuba, Japan. FAU - Win-Shwe, Tin-Tin AU - Win-Shwe TT AD - 1 Center for Health and Environmental Risk Research, National Institute for Environmental Studies, Tsukuba, Japan. FAU - Takano, Hirohisa AU - Takano H AD - 2 Graduate School of Engineering, Kyoto University, Kyoto, Japan. LA - eng PT - Journal Article PL - England TA - Int J Immunopathol Pharmacol JT - International journal of immunopathology and pharmacology JID - 8911335 RN - 0 (Benzhydryl Compounds) RN - 0 (Cytokines) RN - 0 (Environmental Pollutants) RN - 0 (Estrogen Receptor beta) RN - 0 (Immunoglobulins) RN - 0 (Inflammation Mediators) RN - 0 (Phenols) RN - 0 (RNA, Messenger) RN - 9006-59-1 (Ovalbumin) RN - MLT3645I99 (bisphenol A) RN - W980KJ009P (Corticosterone) SB - IM MH - Age Factors MH - Animals MH - Benzhydryl Compounds/*toxicity MH - Cells, Cultured MH - Corticosterone/blood MH - Cytokines/metabolism MH - Disease Models, Animal MH - Environmental Pollutants/*toxicity MH - Estrogen Receptor beta/genetics/metabolism MH - Immunoglobulins/blood MH - Inflammation Mediators/metabolism MH - Lung/*drug effects/immunology/metabolism/pathology MH - Lymph Nodes/drug effects/immunology/metabolism MH - Male MH - Mice, Inbred C3H MH - Ovalbumin MH - Phenols/*toxicity MH - RNA, Messenger/genetics/metabolism MH - Respiratory Hypersensitivity/*chemically induced/immunology/metabolism/pathology MH - Spleen/drug effects/immunology/metabolism MH - Th2 Cells/*drug effects/immunology/metabolism PMC - PMC5946358 OTO - NOTNLM OT - allergic airway inflammation OT - bisphenol A OT - endocrine-disrupting chemicals OT - immune system disruption OT - inflammatory/anti-inflammatory mediators COIS- Declaration of conflicting interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. EDAT- 2018/05/09 06:00 MHDA- 2018/10/04 06:00 PMCR- 2018/05/08 CRDT- 2018/05/09 06:00 PHST- 2018/05/09 06:00 [entrez] PHST- 2018/05/09 06:00 [pubmed] PHST- 2018/10/04 06:00 [medline] PHST- 2018/05/08 00:00 [pmc-release] AID - 10.1177_2058738418774897 [pii] AID - 10.1177/2058738418774897 [doi] PST - ppublish SO - Int J Immunopathol Pharmacol. 2018 Jan-Dec;32:2058738418774897. doi: 10.1177/2058738418774897.